Answers are grounded in this paper and cite their sources.
The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.
No takes yet. Share an insight, caveat, or question.
Crest et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: